Bhavya Doshi is an Oncology physician affiliated with Emory University. OpenAlex indexes 47 publications with 615 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RegeneronProgram year20256 paymentsResearch$56,869openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20257 payments$11,316openpaymentsdata.cms.gov ↗
- CSL BehringProgram year20257 payments$10,910openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2025–2026 per NIH RePORTER. The latest:
- Mechanistic insights into factor VIII inhibitor formation and eradication
Emory University
FY2025$155,165K99HL156073
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PB2067 Canine FIXa homodimeric antibody reduces annualized bleeding and infusion rates in severe hemophilia A dogs with canine FVIII inhibitors
Research and Practice in Thrombosis and Haemostasis
2026 - PB1467 Maternal FVIII Can Be the First FVIII Exposure in Neonates with Severe Hemophilia A
Research and Practice in Thrombosis and Haemostasis
2026 - Cardiotoxic Effects and Microdystrophin Expression after Gene Therapy for DMD
New England Journal of Medicine
2026 - Adeno-associated viral vector gene therapy for canine hemophilia
Rare Disease and Orphan Drugs Journal
2026 - Use of CD19-targeted immune modulation to eradicate AAV-neutralizing antibodies
Molecular Therapy
2025
Similar KOLs
Other experts from the same institution or the same specialty.
James Lah, MD
Emory University
Vasilis Babaliaros, MD
Emory University
Keith Delman, MD
Emory University
John Puskas, MD
Emory University
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”